RIGL EBITDA Margin
Rigel Pharmaceuticals Inc · EBITDA Margin
RIGL EBITDA Margin
Latest reported33.97%period ending
RIGL EBITDA Margin (-113.25% → 33.97%)
Annual ebitda margin
High-resolution chart · PNG
RIGL ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 44.7061% | |
| 15.9038% | |
| -14.5283% | |
| -44.7997% | |
| -7.5632% | |
| -25.4877% | |
| -111.1119% | |
| -157.0154% | |
| -1,728.9697% | |
| -309.2283% | |
| -174.0924% | |
| -1,077.4545% | |
| -1,191.5804% | |
| -4,308.6222% | |
| -1,768.2737% | |
| 31.4384% | |
| -14,671.2% | |
| 0% | |
| -631.1667% | |
| -124.3659% | |
| -282.8392% | |
| -1,151.3628% | |
| -340.5699% | |
| -197.5678% | |
| -118.9309% | |
| -135.7845% | |
| -113.2458% |